SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-15-002925
Filing Date
2015-11-13
Accepted
2015-11-13 10:13:16
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q medizone10q093015.htm 10-Q 389395
2 EX-31.1 ex31-1.htm EX-31.1 10212
3 EX-31.2 ex31-2.htm EX-31.2 10106
4 EX-32.1 ex32-1.htm EX-32.1 4373
5 EX-32.2 ex32-2.htm EX-32.2 4554
  Complete submission text file 0001185185-15-002925.txt   2158160

Data Files

Seq Description Document Type Size
6 EX-101.INS mzei-20150930.xml EX-101.INS 304658
7 EX-101.SCH mzei-20150930.xsd EX-101.SCH 27165
8 EX-101.CAL mzei-20150930_cal.xml EX-101.CAL 22187
9 EX-101.DEF mzei-20150930_def.xml EX-101.DEF 131736
10 EX-101.LAB mzei-20150930_lab.xml EX-101.LAB 199969
11 EX-101.PRE mzei-20150930_pre.xml EX-101.PRE 133054
Mailing Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965
Business Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 002-93277-D | Film No.: 151227359
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries